欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/1801/001
药品名称Plenvu
活性成分
    • ascorbic acid 7.54 g
    • macrogol 140.0 g
    • potassium chloride 2.2 g
    • sodium ascorbate 48.11 g
    • sodium chloride 5.2 g
    • SODIUM SULFATE 9.0 g
剂型Powder for oral solution
上市许可持有人Norgine BV The Netherlands
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
    • Germany (DE)
      PLENVU Pulver zur Herstellung einer Lösung zum Einnehmen
    • Denmark (DK)
    • Belgium (BE)
      Plenvu
    • Netherlands (NL)
    • Luxembourg (LU)
    • Iceland (IS)
      Plenvu Mixtúruduft, lausn
    • Ireland (IE)
    • Austria (AT)
      PLEINVUE Pulver zur Herstellung einer Lösung zum Einnehmen
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Norway (NO)
      Plenvu
    • Finland (FI)
    • Poland (PL)
    • Hungary (HU)
      PLENVU por belsőleges oldathoz
    • Bulgaria (BG)
      Plenvu
    • Czechia (CZ)
      Plenvu
    • Romania (RO)
    • Slovakia (SK)
      Plenvu
    • Slovenia (SI)
    • Croatia (HR)
      Plenvu prašak za oralnu otopinu
许可日期2017/09/28
最近更新日期2024/06/11
药物ATC编码
    • A06AD65 macrogol, combinations
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase